A Randomized Phase II Study of Amifostine Used As Stem Cell Protectant in Non-Hodgkin Lymphoma Patients Receiving Cisplatin-Based Salvage Chemotherapy Prior to Stem Cell Transplant

2001 ◽  
Vol 10 (6) ◽  
pp. 887-893 ◽  
Author(s):  
Christos Emmanouilides ◽  
Mary Territo ◽  
Jeffrey Andrey ◽  
James Mason
Keyword(s):  
Stem Cell ◽  
Hodgkin Lymphoma ◽  
Phase Ii ◽  
Stem Cell Transplant ◽  
Phase Ii Study ◽  
Salvage Chemotherapy ◽  
Cell Transplant ◽  
Non Hodgkin Lymphoma ◽  
Randomized Phase Ii

scholarly journals Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant

2009 ◽  
Vol 84 (8) ◽  
pp. 484-487 ◽  
Author(s):  
Paul M. Barr ◽  
Hillard M. Lazarus ◽  
Brenda W. Cooper ◽  
Mark D. Schluchter ◽  
Ashok Panneerselvam ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hodgkin Lymphoma ◽  
Phase Ii ◽  
Stem Cell Transplant ◽  
Phase Ii Study ◽  
Autologous Stem Cell Transplant ◽  
Cell Transplant ◽  
Bryostatin 1 ◽  
Non Hodgkin Lymphoma

scholarly journals Comorbidities, Not Age, Impact Outcomes in Autologous Stem Cell Transplant for Relapsed Non-Hodgkin Lymphoma

2008 ◽  
Vol 14 (7) ◽  
pp. 840-846 ◽  
Author(s):  
Tanya M. Wildes ◽  
Kristan M. Augustin ◽  
Diane Sempek ◽  
Qin Jean Zhang ◽  
Ravi Vij ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hodgkin Lymphoma ◽  
Stem Cell Transplant ◽  
Autologous Stem Cell Transplant ◽  
Cell Transplant ◽  
Non Hodgkin Lymphoma

High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era

2014 ◽  
Vol 55 (10) ◽  
pp. 2319-2327 ◽  
Author(s):  
Yngvild N. Blaker ◽  
Marianne B. Eide ◽  
Knut Liestøl ◽  
Grete F. Lauritzsen ◽  
Arne Kolstad ◽  
...  
Keyword(s):  
Stem Cell ◽  
B Cell ◽  
Hodgkin Lymphoma ◽  
Stem Cell Transplant ◽  
High Dose Chemotherapy ◽  
Autologous Stem Cell Transplant ◽  
High Dose ◽  
Cell Transplant ◽  
Non Hodgkin Lymphoma
Sign in / Sign up

Export Citation Format

Share Document